The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 13, 2022
Filed:
Jul. 24, 2020
Applicants:
Santen Pharmaceutical Co., Ltd., Osaka, JP;
Daiichi Sankyo Company, Limited, Tokyo, JP;
Inventors:
Assignees:
SANTEN PHARMACEUTICAL CO., LTD., Osaka, JP;
DAIICHI SANYO COMPANY, LIMITED, Tokyo, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/661 (2006.01); A61K 9/08 (2006.01); A61K 31/573 (2006.01); A61K 31/5383 (2006.01); A61P 27/02 (2006.01); A61P 31/04 (2006.01); A61K 9/00 (2006.01); A61K 47/10 (2017.01); A61K 47/02 (2006.01); A61P 29/00 (2006.01); A61K 31/496 (2006.01); A61K 31/538 (2006.01); C07J 5/00 (2006.01); C07C 31/18 (2006.01); C08G 65/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/661 (2013.01); A61K 9/0048 (2013.01); A61K 9/08 (2013.01); A61K 31/496 (2013.01); A61K 31/538 (2013.01); A61K 31/5383 (2013.01); A61K 31/573 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61P 27/02 (2018.01); A61P 29/00 (2018.01); A61P 31/04 (2018.01); C07J 5/0046 (2013.01); C07C 31/18 (2013.01); C08G 65/00 (2013.01);
Abstract
An ophthalmic aqueous composition comprises levofloxacin, a salt thereof, or a solvate thereof; dexamethasone, an ester thereof, or a salt thereof; and one or at least two isotonic agents. The ophthalmic aqueous composition is substantially free of sodium chloride. This ophthalmic aqueous composition is excellent in drug stability and drug migration and has a clear appearance.